Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO)
Titel:
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO)
Auteur:
Levy, Benjamin Barlesi, Fabrice Paz-Ares, Luis Bennouna, Jaafar Erman, Mustafa Felip, Enriqueta Isla, Dolores Ryun Kim, Hye Kim, Sang-We Madelaine, Jeannick Molinier, Olivier Özgüroğlu, Mustafa Rodríguez Abreu, Delvys Adeniji, Abidemi Lorence, Robert M. Voccia, Isabelle Chisamore, Michael J. Riess, Jonathan W.